Pep Gubau, Aizon CEO
Exclusive: With an eye toward expansion, an AI company that supports CDMOs completes $20M Series C raise
An AI provider that caters to biopharma manufacturers has closed a $20 million Series C raise to expand its operations and bring its third tech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
